238 related articles for article (PubMed ID: 15717278)
1. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys.
Kochel TJ; Watts DM; Gozalo AS; Ewing DF; Porter KR; Russell KL
J Infect Dis; 2005 Mar; 191(6):1000-4. PubMed ID: 15717278
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys.
Blair PJ; Kochel TJ; Raviprakash K; Guevara C; Salazar M; Wu SJ; Olson JG; Porter KR
Vaccine; 2006 Feb; 24(9):1427-32. PubMed ID: 16214271
[TBL] [Abstract][Full Text] [Related]
3. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of interferences between dengue vaccine serotypes in a monkey model.
Guy B; Barban V; Mantel N; Aguirre M; Gulia S; Pontvianne J; Jourdier TM; Ramirez L; Gregoire V; Charnay C; Burdin N; Dumas R; Lang J
Am J Trop Med Hyg; 2009 Feb; 80(2):302-11. PubMed ID: 19190230
[TBL] [Abstract][Full Text] [Related]
5. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Endy TP; Raengsakulrach B; Rothman AL; Ennis FA; Nisalak A
J Infect Dis; 2000 Jan; 181(1):2-9. PubMed ID: 10608744
[TBL] [Abstract][Full Text] [Related]
6. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
[TBL] [Abstract][Full Text] [Related]
7. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
[TBL] [Abstract][Full Text] [Related]
8. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
Kuruvilla JG; Troyer RM; Devi S; Akkina R
Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
[TBL] [Abstract][Full Text] [Related]
9. Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus).
Azami NAM; Moi ML; Ami Y; Suzaki Y; Lim CK; Taniguchi S; Saijo M; Takasaki T; Kurane I
Virol J; 2018 Mar; 15(1):51. PubMed ID: 29587780
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
[TBL] [Abstract][Full Text] [Related]
11. Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.
Butrapet S; Rabablert J; Angsubhakorn S; Wiriyarat W; Huang C; Kinney R; Punyim S; Bhamarapravati N
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):589-99. PubMed ID: 12693596
[TBL] [Abstract][Full Text] [Related]
12. A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults.
Morrison D; Legg TJ; Billings CW; Forrat R; Yoksan S; Lang J
J Infect Dis; 2010 Feb; 201(3):370-7. PubMed ID: 20059357
[TBL] [Abstract][Full Text] [Related]
13. Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins.
Bernardo L; Hermida L; Martin J; Alvarez M; Prado I; López C; Martínez R; Rodríguez-Roche R; Zulueta A; Lazo L; Rosario D; Guillén G; Guzmán MG
Arch Virol; 2008; 153(5):849-54. PubMed ID: 18299795
[TBL] [Abstract][Full Text] [Related]
14. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
[TBL] [Abstract][Full Text] [Related]
15. A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys.
Kochel TJ; Raviprakash K; Hayes CG; Watts DM; Russell KL; Gozalo AS; Phillips IA; Ewing DF; Murphy GS; Porter KR
Vaccine; 2000 Jul; 18(27):3166-73. PubMed ID: 10856796
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of dengue virus in the presence of Fc receptor-mediated phagocytosis distinguishes serotype-specific from cross-neutralizing antibodies.
Wu RS; Chan KR; Tan HC; Chow A; Allen JC; Ooi EE
Antiviral Res; 2012 Dec; 96(3):340-3. PubMed ID: 23041143
[TBL] [Abstract][Full Text] [Related]
17. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.
Raviprakash K; Apt D; Brinkman A; Skinner C; Yang S; Dawes G; Ewing D; Wu SJ; Bass S; Punnonen J; Porter K
Virology; 2006 Sep; 353(1):166-73. PubMed ID: 16814355
[TBL] [Abstract][Full Text] [Related]
18. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
[TBL] [Abstract][Full Text] [Related]
19. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
20. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies.
Martin NC; Pardo J; Simmons M; Tjaden JA; Widjaja S; Marovich MA; Sun W; Porter KR; Burgess TH
J Virol Methods; 2006 Jun; 134(1-2):74-85. PubMed ID: 16417930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
